(+)-pilocarpine multiple interactions EXP 6480464 1 more ... CTD PMID:30542433 , PMID:31018114 (+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of GFAP protein CTD PMID:30542433 (+)-pilocarpine decreases expression EXP 6480464 Pilocarpine results in decreased expression of GFAP protein CTD PMID:25101675 (R)-lipoic acid decreases expression ISO RGD:10633 6480464 Thioctic Acid results in decreased expression of GFAP mRNA CTD PMID:19555370 (R,R,R)-alpha-tocopherol increases expression EXP 6480464 alpha-Tocopherol results in increased expression of GFAP protein CTD PMID:18942769 (S)-amphetamine increases expression ISO RGD:10633 6480464 Dextroamphetamine results in increased expression of GFAP protein CTD PMID:15337264 (S)-nicotine increases expression ISO RGD:10633 6480464 Nicotine results in increased expression of GFAP mRNA CTD PMID:17997037 (S)-nicotine decreases expression ISO RGD:10633 6480464 Nicotine results in decreased expression of GFAP mRNA CTD PMID:21955143 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane decreases expression ISO RGD:619574 6480464 2, 2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased expression of GFAP mRNA CTD PMID:16580782 1,2-dichloroethane increases expression ISO RGD:10633 6480464 ethylene dichloride results in increased expression of GFAP mRNA CTD PMID:28960355 1,3,5-trinitro-1,3,5-triazinane increases expression EXP 6480464 cyclonite results in increased expression of GFAP mRNA CTD PMID:25559034 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:10633 6480464 [1-Methyl-4-phenyl-1 more ... CTD PMID:16809432 more ... 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:10633 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:19199078 more ... 15-deoxy-Delta(12,14)-prostaglandin J2 increases expression ISO RGD:619574 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in increased expression of GFAP CTD PMID:15254749 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression EXP 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in decreased expression of GFAP mRNA CTD PMID:15994020 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions EXP 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA] CTD PMID:15994020 17alpha-ethynylestradiol affects expression ISO RGD:10633 6480464 Ethinyl Estradiol affects the expression of GFAP mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:10633 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GFAP mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GFAP mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:10633 6480464 [Estradiol co-treated with Progesterone] promotes the reaction [Cuprizone results in increased expression of GFAP mRNA] CTD PMID:19031445 17beta-estradiol multiple interactions EXP 6480464 Estradiol affects the reaction [Estrogens deficiency results in increased expression of GFAP protein alternative form] CTD PMID:30565903 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:33078273 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10633 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GFAP mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GFAP mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GFAP mRNA CTD PMID:19490992 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10633 6480464 Tetrachlorodibenzodioxin affects the expression of GFAP mRNA CTD PMID:18343893 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:10633 6480464 2 more ... CTD PMID:18343893 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-D increases expression EXP 6480464 2, 4-Dichlorophenoxyacetic Acid results in increased expression of GFAP mRNA CTD PMID:22954530 2,4-dinitrobenzenesulfonic acid increases expression ISO RGD:10633 6480464 2, 4-dinitrobenzenesulfonic acid results in increased expression of GFAP mRNA CTD PMID:30116771 2,4-dinitrobenzenesulfonic acid multiple interactions ISO RGD:10633 6480464 GR 159897 inhibits the reaction [2, 4-dinitrobenzenesulfonic acid results in increased expression of GFAP mRNA] CTD PMID:30116771 2,5-hexanedione increases expression EXP 6480464 2, 5-hexanedione results in increased expression of GFAP protein CTD PMID:19033394 2,5-hexanedione decreases expression EXP 6480464 2, 5-hexanedione results in decreased expression of GFAP protein CTD PMID:19033394 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions EXP 6480464 Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein], Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] CTD PMID:21863293 , PMID:21879721 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile increases expression EXP 6480464 Verapamil results in increased expression of GFAP mRNA CTD PMID:22954530 2-Ethylhexanoic acid decreases expression ISO RGD:10633 6480464 2-ethylhexanoic acid results in decreased expression of GFAP mRNA CTD PMID:30578912 3',5'-cyclic AMP multiple interactions ISO RGD:619574 6480464 [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in increased expression of GFAP mRNA CTD PMID:33713149 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:10633 6480464 tetrabromobisphenol A results in decreased expression of GFAP mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of GFAP protein CTD PMID:16489401 3,4-methylenedioxymethamphetamine increases expression ISO RGD:10633 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of GFAP protein CTD PMID:15337264 , PMID:19882200 3,4-methylenedioxymethamphetamine multiple interactions ISO RGD:10633 6480464 Caffeine promotes the reaction [N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of GFAP protein] CTD PMID:19882200 3,5-dichloro-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxybenzamide multiple interactions ISO RGD:10633 6480464 Raclopride inhibits the reaction [Methamphetamine results in increased expression of GFAP protein] CTD PMID:16088948 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases expression EXP 6480464 musk ketone results in increased expression of GFAP mRNA CTD PMID:22954530 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GFAP mRNA CTD PMID:36041667 5-fluorouracil increases expression ISO RGD:10633 6480464 Fluorouracil results in increased expression of GFAP protein CTD PMID:21296659 6-Cyano-7-nitroquinoxaline-2,3-dione multiple interactions EXP 6480464 6-Cyano-7-nitroquinoxaline-2, 3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] CTD PMID:21863293 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of GFAP mRNA, Propylthiouracil results in increased expression of GFAP protein CTD PMID:22504374 , PMID:24780913 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of GFAP mRNA CTD PMID:24780913 6alpha-methylprednisolone decreases expression ISO RGD:619574 6480464 Methylprednisolone results in decreased expression of GFAP protein CTD PMID:18509235 7-NITROINDAZOLE multiple interactions EXP 6480464 7-nitroindazole inhibits the reaction [Capsaicin results in increased expression of GFAP protein] more ... CTD PMID:20826152 8-Br-cAMP increases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GFAP mRNA CTD PMID:15994020 8-Br-cAMP multiple interactions EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA] CTD PMID:15994020 8-OH-DPAT multiple interactions ISO RGD:10633 6480464 8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [[Sarin co-treated with 2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide] results in increased expression of GFAP protein] CTD PMID:23692952 abacavir increases expression ISO RGD:619574 6480464 abacavir results in increased expression of GFAP protein CTD PMID:19358275 acetamide increases expression EXP 6480464 acetamide results in increased expression of GFAP mRNA CTD PMID:31881176 acetic acid decreases expression ISO RGD:10633 6480464 Acetic Acid results in decreased expression of GFAP protein CTD PMID:21296659 acetylsalicylic acid decreases expression ISO RGD:619574 6480464 Aspirin results in decreased expression of GFAP mRNA, Aspirin results in decreased expression of GFAP protein CTD PMID:16516312 acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of GFAP mRNA CTD PMID:22954530 acetylsalicylic acid decreases expression ISO RGD:10633 6480464 Aspirin results in decreased expression of GFAP mRNA CTD PMID:21353610 acrolein increases expression EXP 6480464 Acrolein results in increased expression of GFAP protein CTD PMID:31639409 acrolein multiple interactions EXP 6480464 3-(formylhydroxyamino)-2-(3-phenyl-1-propyl)butanoic acid (2, 2-dimethyl-1-methylcarbamoyl-1-propyl)amide inhibits the reaction [Acrolein results in increased expression of GFAP protein] CTD PMID:31639409 acrylamide increases expression ISO RGD:619574 6480464 Acrylamide results in increased expression of GFAP protein CTD PMID:19426797 acrylamide decreases expression ISO RGD:619574 6480464 Acrylamide results in decreased expression of GFAP mRNA, Acrylamide results in decreased expression of GFAP protein CTD PMID:32763439 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of GFAP mRNA CTD PMID:36328537 Aflatoxin B2 alpha decreases methylation ISO RGD:619574 6480464 aflatoxin B2 results in decreased methylation of GFAP exon CTD PMID:30157460 agmatine multiple interactions ISO RGD:10633 6480464 Agmatine inhibits the reaction [MBP protein results in increased expression of GFAP protein], NOS2 gene mutant form promotes the reaction [Agmatine inhibits the reaction [MBP protein results in increased expression of GFAP protein]] CTD PMID:24070732 agomelatine multiple interactions EXP 6480464 agomelatine inhibits the reaction [Galactose results in increased expression of GFAP protein] CTD PMID:34673010 all-trans-retinoic acid multiple interactions ISO RGD:619574 6480464 [Tretinoin co-treated with Paclitaxel] results in increased expression of GFAP protein CTD PMID:18098270 all-trans-retinoic acid multiple interactions ISO RGD:10633 6480464 Tretinoin inhibits the reaction [Dietary Fats promotes the reaction [Lead results in increased expression of GFAP protein]], Tretinoin inhibits the reaction [Lead promotes the reaction [Dietary Fats results in increased expression of GFAP protein]] CTD PMID:34742682 all-trans-retinoic acid affects expression ISO RGD:619574 6480464 Tretinoin affects the expression of GFAP mRNA CTD PMID:31600526 all-trans-retinoic acid increases expression ISO RGD:10633 6480464 Tretinoin results in increased expression of GFAP mRNA, Tretinoin results in increased expression of GFAP protein CTD PMID:11311979 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of GFAP protein CTD PMID:16944780 all-trans-retinoic acid increases expression ISO RGD:619574 6480464 Tretinoin results in increased expression of GFAP mRNA, Tretinoin results in increased expression of GFAP protein CTD PMID:17960384 more ... alpha,alpha-trehalose multiple interactions ISO RGD:10633 6480464 Trehalose inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 alpha-D-galactose increases expression EXP 6480464 Galactose results in increased expression of GFAP protein CTD PMID:34673010 alpha-D-galactose multiple interactions EXP 6480464 agomelatine inhibits the reaction [Galactose results in increased expression of GFAP protein], Melatonin inhibits the reaction [Galactose results in increased expression of GFAP protein] CTD PMID:34673010 aluminium atom increases expression EXP 6480464 Aluminum results in increased expression of GFAP protein CTD PMID:16545059 aluminium atom multiple interactions ISO RGD:10633 6480464 [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of GFAP protein CTD PMID:31363819 aluminium atom multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Aluminum results in increased expression of GFAP protein] CTD PMID:16545059 aluminium(0) increases expression EXP 6480464 Aluminum results in increased expression of GFAP protein CTD PMID:16545059 aluminium(0) multiple interactions ISO RGD:10633 6480464 [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of GFAP protein CTD PMID:31363819 aluminium(0) multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Aluminum results in increased expression of GFAP protein] CTD PMID:16545059 amentoflavone multiple interactions ISO RGD:10633 6480464 amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:28185818 aminoguanidine multiple interactions EXP 6480464 [7-nitroindazole co-treated with pimagedine] promotes the reaction [Capsaicin results in increased expression of GFAP protein] more ... CTD PMID:20826152 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of GFAP mRNA CTD PMID:22954530 , PMID:25659768 amitriptyline increases expression EXP 6480464 Amitriptyline results in increased expression of GFAP mRNA CTD PMID:22954530 ammonia multiple interactions ISO RGD:619574 6480464 IL1B protein promotes the reaction [Ammonia results in decreased expression of GFAP mRNA] CTD PMID:20217200 ammonia decreases expression ISO RGD:619574 6480464 Ammonia results in decreased expression of GFAP mRNA CTD PMID:20217200 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of GFAP mRNA, Ammonium Chloride results in decreased expression of GFAP protein CTD PMID:16483693 amphetamine increases expression ISO RGD:619574 6480464 Amphetamine results in increased expression of GFAP protein CTD PMID:15814102 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of GFAP mRNA, Amphetamine results in increased expression of GFAP protein CTD PMID:15183010 , PMID:20223277 antimony(0) multiple interactions ISO RGD:10633 6480464 [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein CTD PMID:34571074 antimony(0) multiple interactions EXP 6480464 666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein] more ... CTD PMID:34571074 apocynin multiple interactions ISO RGD:10633 6480464 acetovanillone inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of GFAP protein] CTD PMID:30797899 aristolochic acid A increases expression ISO RGD:619574 6480464 aristolochic acid I results in increased expression of GFAP mRNA CTD PMID:33212167 Aroclor 1254 increases expression ISO RGD:10633 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of GFAP mRNA CTD PMID:34265337 arsane affects methylation ISO RGD:619574 6480464 Arsenic affects the methylation of GFAP gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:619574 6480464 Arsenic affects the methylation of GFAP gene CTD PMID:25304211 astaxanthin decreases expression ISO RGD:10633 6480464 astaxanthine results in decreased expression of GFAP mRNA CTD PMID:19555370 atrazine decreases expression ISO RGD:619574 6480464 Atrazine results in decreased expression of GFAP mRNA CTD PMID:34146662 benzo[a]pyrene decreases expression ISO RGD:10633 6480464 Benzo(a)pyrene results in decreased expression of GFAP mRNA CTD PMID:20127859 benzo[a]pyrene increases methylation ISO RGD:619574 6480464 Benzo(a)pyrene results in increased methylation of GFAP 3' UTR more ... CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:619574 6480464 Benzo(a)pyrene results in decreased expression of GFAP mRNA CTD PMID:22316170 benzo[e]pyrene decreases methylation ISO RGD:619574 6480464 benzo(e)pyrene results in decreased methylation of GFAP exon CTD PMID:30157460 berberine multiple interactions EXP 6480464 Berberine inhibits the reaction [Bortezomib results in increased expression of GFAP mRNA] CTD PMID:35121005 bis(2-ethylhexyl) phthalate increases expression ISO RGD:10633 6480464 Diethylhexyl Phthalate results in increased expression of GFAP protein CTD PMID:28934723 bisphenol A multiple interactions ISO RGD:10633 6480464 Tamoxifen inhibits the reaction [bisphenol A results in increased expression of GFAP protein] CTD PMID:16860915 bisphenol A decreases expression ISO RGD:619574 6480464 bisphenol A results in decreased expression of GFAP protein CTD PMID:35069845 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GFAP mRNA CTD PMID:30816183 more ... bisphenol A decreases methylation ISO RGD:10633 6480464 bisphenol A results in decreased methylation of GFAP promoter CTD PMID:27312807 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GFAP mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:10633 6480464 bisphenol A results in increased expression of GFAP mRNA, bisphenol A results in increased expression of GFAP protein CTD PMID:16684133 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GFAP mRNA, Curcumin inhibits the reaction [bisphenol A results in increased expression of GFAP mRNA] CTD PMID:25963729 , PMID:36041667 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GFAP mRNA, bisphenol A results in increased expression of GFAP protein CTD PMID:25381574 more ... bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GFAP mRNA CTD PMID:36041667 bortezomib multiple interactions EXP 6480464 Berberine inhibits the reaction [Bortezomib results in increased expression of GFAP mRNA] CTD PMID:35121005 bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of GFAP mRNA CTD PMID:35121005 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of GFAP protein CTD PMID:28903499 bromochloroacetic acid decreases expression ISO RGD:10633 6480464 bromochloroacetic acid results in decreased expression of GFAP protein CTD PMID:21296659 cadmium dichloride increases expression ISO RGD:619574 6480464 Cadmium Chloride results in increased expression of GFAP protein CTD PMID:21796402 cadmium dichloride increases expression ISO RGD:10633 6480464 Cadmium Chloride results in increased expression of GFAP mRNA CTD PMID:24982889 cadmium dichloride multiple interactions EXP 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:20829427 more ... cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of GFAP protein CTD PMID:20829427 caffeine multiple interactions ISO RGD:10633 6480464 Caffeine promotes the reaction [N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of GFAP protein] CTD PMID:19882200 caffeine multiple interactions EXP 6480464 Caffeine inhibits the reaction [aluminum chloride results in increased expression of GFAP protein] CTD PMID:26339337 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of GFAP mRNA CTD PMID:17293106 calcitriol affects expression ISO RGD:10633 6480464 Calcitriol affects the expression of GFAP mRNA CTD PMID:15138306 calcium atom multiple interactions EXP 6480464 Calcium affects the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein], Calcium deficiency inhibits the reaction [Ethanol results in increased expression of GFAP protein] CTD PMID:17888892 , PMID:21879721 calcium(0) multiple interactions EXP 6480464 Calcium affects the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein], Calcium deficiency inhibits the reaction [Ethanol results in increased expression of GFAP protein] CTD PMID:17888892 , PMID:21879721 calyculin a multiple interactions EXP 6480464 calyculin A inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] CTD PMID:21863293 cannabidiol multiple interactions ISO RGD:619574 6480464 [Cannabidiol co-treated with moringin] results in increased expression of GFAP protein CTD PMID:30096889 capsaicin increases expression ISO RGD:619574 6480464 Capsaicin results in increased expression of GFAP mRNA CTD PMID:18405923 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of GFAP protein CTD PMID:20826152 capsaicin multiple interactions EXP 6480464 7-nitroindazole inhibits the reaction [Capsaicin results in increased expression of GFAP protein] more ... CTD PMID:19285962 , PMID:20826152 capsazepine multiple interactions EXP 6480464 capsazepine inhibits the reaction [Capsaicin results in increased expression of GFAP protein] CTD PMID:20826152 capsazepine multiple interactions ISO RGD:10633 6480464 capsazepine inhibits the reaction [Olanzapine results in increased expression of GFAP mRNA] CTD PMID:32652086 captan multiple interactions ISO RGD:10633 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of GFAP protein CTD PMID:32736067 carbendazim increases expression EXP 6480464 carbendazim results in increased expression of GFAP protein CTD PMID:35513110 carbofuran decreases expression EXP 6480464 Carbofuran results in decreased expression of GFAP protein CTD PMID:22240977 carbofuran increases expression EXP 6480464 Carbofuran results in increased expression of GFAP mRNA CTD PMID:28982980 carbonyl sulfide affects expression EXP 6480464 carbonyl sulfide affects the expression of GFAP mRNA CTD PMID:19395590 carmustine multiple interactions EXP 6480464 Melatonin inhibits the reaction [Carmustine results in decreased expression of GFAP protein] CTD PMID:17572393 carmustine decreases expression EXP 6480464 Carmustine results in decreased expression of GFAP protein CTD PMID:17572393 carmustine decreases expression ISO RGD:619574 6480464 Carmustine results in decreased expression of GFAP mRNA CTD PMID:15980968 carvacrol multiple interactions EXP 6480464 carvacrol inhibits the reaction [propiconazole results in increased expression of GFAP protein] CTD PMID:29852196 chlordecone increases expression ISO RGD:10633 6480464 Chlordecone results in increased expression of GFAP mRNA CTD PMID:29980752 chlorpromazine affects expression EXP 6480464 Chlorpromazine affects the expression of GFAP mRNA CTD PMID:31324950 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of GFAP mRNA CTD PMID:17452286 , PMID:20691718 chlorpyrifos multiple interactions ISO RGD:10633 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of GFAP protein CTD PMID:32736067 chlorpyrifos increases expression ISO RGD:619574 6480464 Chlorpyrifos results in increased expression of GFAP mRNA, Chlorpyrifos results in increased expression of GFAP protein CTD PMID:31136966 chlorpyrifos multiple interactions EXP 6480464 [Chlorpyrifos co-treated with Lipopolysaccharides] results in increased expression of GFAP protein more ... CTD PMID:30236991 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of GFAP mRNA CTD PMID:16675515 choline multiple interactions ISO RGD:10633 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GFAP gene CTD PMID:20938992 chrysin multiple interactions EXP 6480464 chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP mRNA], chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP protein] CTD PMID:33121995 Citreoviridin affects expression ISO RGD:10633 6480464 citreoviridin affects the expression of GFAP mRNA CTD PMID:30071239 clofibrate multiple interactions ISO RGD:10633 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GFAP mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GFAP mRNA] CTD PMID:17585979 clotrimazole increases expression ISO RGD:619574 6480464 Clotrimazole results in increased expression of GFAP protein CTD PMID:10223459 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of GFAP protein CTD PMID:18585900 clozapine increases expression EXP 6480464 Clozapine results in increased expression of GFAP mRNA CTD PMID:19441803 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of GFAP mRNA, cobaltous chloride results in increased expression of GFAP protein CTD PMID:23978538 , PMID:30551423 cobalt dichloride multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [cobaltous chloride results in increased expression of GFAP protein] CTD PMID:30551423 cocaine increases expression ISO RGD:619574 6480464 Cocaine results in increased expression of GFAP protein CTD PMID:15814102 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of GFAP protein CTD PMID:11391778 cocaine affects expression EXP 6480464 Cocaine affects the expression of GFAP mRNA, Cocaine affects the expression of GFAP protein CTD PMID:12670315 , PMID:20187946 cocaine affects expression ISO RGD:10633 6480464 Cocaine affects the expression of GFAP protein CTD PMID:11882367 coenzyme Q10 decreases expression ISO RGD:10633 6480464 coenzyme Q10 results in decreased expression of GFAP mRNA CTD PMID:19555370 coenzyme Q10 multiple interactions EXP 6480464 [Oxygen co-treated with coenzyme Q10] results in decreased expression of GFAP protein CTD PMID:35212449 colforsin daropate hydrochloride decreases expression ISO RGD:619574 6480464 Colforsin results in decreased expression of GFAP protein CTD PMID:34897981 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of GFAP mRNA CTD PMID:26033743 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of GFAP mRNA CTD PMID:26033743 Cuprizon multiple interactions ISO RGD:10633 6480464 [Estradiol co-treated with Progesterone] promotes the reaction [Cuprizone results in increased expression of GFAP mRNA] CTD PMID:19031445 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of GFAP mRNA, Cuprizone results in increased expression of GFAP protein CTD PMID:27523638 Cuprizon increases expression ISO RGD:10633 6480464 Cuprizone results in increased expression of GFAP mRNA, Cuprizone results in increased expression of GFAP protein CTD PMID:19031445 , PMID:30468814 curcumin decreases expression ISO RGD:10633 6480464 Curcumin results in decreased expression of GFAP mRNA CTD PMID:19555370 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of GFAP mRNA CTD PMID:25963729 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [bisphenol A results in increased expression of GFAP mRNA] CTD PMID:25963729 Cyanoginosin increases degradation EXP 6480464 microcystin analog results in increased degradation of GFAP protein CTD PMID:27864109 cyprodinil multiple interactions ISO RGD:619574 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of GFAP protein] CTD PMID:31939705 cyprodinil multiple interactions ISO RGD:10633 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of GFAP protein CTD PMID:31939705 dabigatran decreases expression ISO RGD:10633 6480464 Dabigatran results in decreased expression of GFAP protein CTD PMID:27397090 dantrolene multiple interactions EXP 6480464 Dantrolene inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein], Dantrolene inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] CTD PMID:21863293 , PMID:21879721 dexamethasone increases expression ISO RGD:619574 6480464 Dexamethasone results in increased expression of GFAP protein CTD PMID:22048647 diazinon affects expression EXP 6480464 Diazinon affects the expression of GFAP mRNA CTD PMID:17452286 dieldrin multiple interactions ISO RGD:10633 6480464 Dieldrin promotes the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:16809432 digoxin increases expression EXP 6480464 Digoxin results in increased expression of GFAP mRNA CTD PMID:22954530 dihydrogen multiple interactions EXP 6480464 Hydrogen inhibits the reaction [[Chlorpyrifos co-treated with Lipopolysaccharides] results in increased expression of GFAP protein] CTD PMID:30236991 dimethoate increases expression EXP 6480464 Dimethoate results in increased expression of GFAP mRNA, Dimethoate results in increased expression of GFAP protein CTD PMID:21941777 dioxygen increases expression ISO RGD:10633 6480464 Oxygen results in increased expression of GFAP protein CTD PMID:25203536 dioxygen multiple interactions EXP 6480464 [Oxygen co-treated with coenzyme Q10] results in decreased expression of GFAP protein more ... CTD PMID:25727173 , PMID:35212449 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:10633 6480464 [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein CTD PMID:34571074 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions EXP 6480464 666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein] more ... CTD PMID:34571074 diprotium multiple interactions EXP 6480464 Hydrogen inhibits the reaction [[Chlorpyrifos co-treated with Lipopolysaccharides] results in increased expression of GFAP protein] CTD PMID:30236991 disodium selenite multiple interactions ISO RGD:10633 6480464 Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased expression of GFAP mRNA] CTD PMID:17997286 disodium selenite decreases expression EXP 6480464 Sodium Selenite results in decreased expression of GFAP mRNA CTD PMID:18209489 dizocilpine maleate multiple interactions EXP 6480464 Dizocilpine Maleate inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] CTD PMID:21863293 dopaminechrome (enol form) decreases expression EXP 6480464 aminochrome 1 results in decreased expression of GFAP protein CTD PMID:29588162 doxorubicin increases oxidation EXP 6480464 Doxorubicin results in increased oxidation of GFAP protein CTD PMID:28818578 ebselen increases phosphorylation EXP 6480464 ebselen results in increased phosphorylation of GFAP protein CTD PMID:27282967 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of GFAP mRNA CTD PMID:29391264 ethanol affects expression EXP 6480464 Ethanol affects the expression of GFAP mRNA, Ethanol affects the expression of GFAP protein CTD PMID:17262233 , PMID:34547370 ethanol affects splicing ISO RGD:10633 6480464 Ethanol affects the splicing of GFAP mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:10633 6480464 Ethanol results in increased expression of GFAP mRNA, Ethanol results in increased expression of GFAP protein CTD PMID:23500890 , PMID:30319688 ethanol multiple interactions ISO RGD:10633 6480464 Ethanol promotes the reaction [Dietary Fats results in increased expression of GFAP mRNA], TLR4 gene mutant form inhibits the reaction [Ethanol results in increased expression of GFAP protein] CTD PMID:23500890 , PMID:35863473 ethanol increases expression EXP 6480464 Ethanol results in increased expression of GFAP protein CTD PMID:17888892 ethanol multiple interactions EXP 6480464 [cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Ethanol] results in increased expression of GFAP mRNA more ... CTD PMID:17888892 , PMID:30098312 ethanol increases expression ISO RGD:619574 6480464 Ethanol results in increased expression of GFAP protein CTD PMID:20621659 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of GFAP mRNA, Ethanol results in decreased expression of GFAP protein CTD PMID:16770775 , PMID:20837132 ethanol decreases expression ISO RGD:10633 6480464 Ethanol results in decreased expression of GFAP mRNA CTD PMID:21955143 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:21879721 fenitrothion multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of GFAP protein] CTD PMID:31173782 fenitrothion increases expression EXP 6480464 Fenitrothion results in increased expression of GFAP protein CTD PMID:31173782 finasteride multiple interactions EXP 6480464 Finasteride inhibits the reaction [Butyrates results in increased expression of GFAP mRNA] more ... CTD PMID:19360904 fisetin multiple interactions EXP 6480464 fisetin inhibits the reaction [methylmercuric chloride results in increased expression of GFAP protein] CTD PMID:30890323 fluoxetine increases response to substance ISO RGD:10633 6480464 GFAP protein results in increased susceptibility to Fluoxetine CTD PMID:22113448 fluoxetine increases expression ISO RGD:10633 6480464 Fluoxetine results in increased expression of GFAP mRNA, Fluoxetine results in increased expression of GFAP protein CTD PMID:20857517 folic acid multiple interactions ISO RGD:10633 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GFAP gene more ... CTD PMID:20938992 , PMID:30502384 folic acid decreases expression ISO RGD:619574 6480464 Folic Acid results in decreased expression of GFAP mRNA CTD PMID:21867686 folic acid decreases expression ISO RGD:10633 6480464 Folic Acid results in decreased expression of GFAP mRNA CTD PMID:25629700 folic acid multiple interactions EXP 6480464 Folic Acid inhibits the reaction [Methotrexate results in decreased expression of GFAP mRNA] CTD PMID:30502384 furan decreases expression EXP 6480464 furan results in decreased expression of GFAP mRNA CTD PMID:25539665 furan increases expression EXP 6480464 furan results in increased expression of GFAP mRNA CTD PMID:25539665 galactose increases expression EXP 6480464 Galactose results in increased expression of GFAP protein CTD PMID:34673010 galactose multiple interactions EXP 6480464 agomelatine inhibits the reaction [Galactose results in increased expression of GFAP protein], Melatonin inhibits the reaction [Galactose results in increased expression of GFAP protein] CTD PMID:34673010 gamma-aminobutyric acid increases expression EXP 6480464 gamma-Aminobutyric Acid results in increased expression of GFAP protein CTD PMID:17845906 gefitinib multiple interactions EXP 6480464 gefitinib inhibits the reaction [HBEGF protein inhibits the reaction [sodium arsenite results in decreased expression of GFAP protein]] CTD PMID:29228391 glufosinate increases expression ISO RGD:10633 6480464 phosphinothricin results in increased expression of GFAP mRNA, phosphinothricin results in increased expression of GFAP protein CTD PMID:27031874 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of GFAP mRNA CTD PMID:24915197 glycidol increases expression EXP 6480464 glycidol results in increased expression of GFAP mRNA CTD PMID:24395379 glyphosate increases expression ISO RGD:619574 6480464 glyphosate results in increased expression of GFAP mRNA, glyphosate results in increased expression of GFAP protein CTD PMID:35485992 haloperidol decreases expression ISO RGD:619574 6480464 Haloperidol results in decreased expression of GFAP protein CTD PMID:34122009 hydrogen peroxide multiple interactions ISO RGD:10633 6480464 Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased expression of GFAP mRNA] CTD PMID:17997286 hydrogen peroxide increases expression ISO RGD:10633 6480464 Hydrogen Peroxide results in increased expression of GFAP mRNA CTD PMID:17997286 hydrogen sulfide increases expression ISO RGD:10633 6480464 Hydrogen Sulfide results in increased expression of GFAP mRNA CTD PMID:31843631 ibuprofen multiple interactions EXP 6480464 Ibuprofen inhibits the reaction [Streptozocin results in increased expression of GFAP mRNA], Ibuprofen inhibits the reaction [Streptozocin results in increased expression of GFAP protein] CTD PMID:24333387 ifosfamide increases expression EXP 6480464 Ifosfamide results in increased expression of GFAP protein CTD PMID:31722249 ifosfamide multiple interactions EXP 6480464 morin inhibits the reaction [Ifosfamide results in increased expression of GFAP protein] CTD PMID:31722249 imidacloprid increases expression EXP 6480464 imidacloprid results in increased expression of GFAP protein CTD PMID:18080902 isoliquiritigenin multiple interactions ISO RGD:10633 6480464 isoliquiritigenin inhibits the reaction [Methamphetamine results in increased expression of GFAP protein] CTD PMID:19834288 isoniazide multiple interactions EXP 6480464 chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP mRNA], chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP protein] CTD PMID:33121995 isoniazide increases expression EXP 6480464 Isoniazid results in increased expression of GFAP mRNA, Isoniazid results in increased expression of GFAP protein CTD PMID:33121995 ivermectin decreases expression ISO RGD:619574 6480464 Ivermectin results in decreased expression of GFAP protein CTD PMID:32959892 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of GFAP mRNA, Kainic Acid results in increased expression of GFAP protein CTD PMID:18711747 more ... kainic acid multiple interactions ISO RGD:619574 6480464 EPO protein inhibits the reaction [Kainic Acid results in increased expression of GFAP protein] CTD PMID:18711747 kainic acid multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of GFAP protein] CTD PMID:32057834 kainic acid multiple interactions ISO RGD:10633 6480464 PTGS2 affects the reaction [Kainic Acid results in increased expression of GFAP mRNA] CTD PMID:21589914 kainic acid increases expression ISO RGD:10633 6480464 Kainic Acid results in increased expression of GFAP mRNA, Kainic Acid results in increased expression of GFAP protein CTD PMID:17997037 , PMID:21589914 ketamine increases expression EXP 6480464 Ketamine results in increased expression of GFAP mRNA CTD PMID:20080153 KN-93 multiple interactions EXP 6480464 KN 93 inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] CTD PMID:21879721 KN-93 multiple interactions ISO RGD:10633 6480464 KN 93 inhibits the reaction [Vincristine results in increased expression of GFAP protein] CTD PMID:34286406 L-ascorbic acid decreases expression EXP 6480464 Ascorbic Acid results in decreased expression of GFAP protein CTD PMID:15372504 L-ascorbic acid multiple interactions ISO RGD:10633 6480464 Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of GFAP protein] CTD PMID:34286406 L-ascorbic acid multiple interactions ISO RGD:619574 6480464 [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in increased expression of GFAP mRNA CTD PMID:33713149 L-methionine multiple interactions ISO RGD:10633 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GFAP gene CTD PMID:20938992 lead diacetate multiple interactions EXP 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:20829427 more ... lead diacetate multiple interactions ISO RGD:10633 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased expression of GFAP mRNA] CTD PMID:36539177 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of GFAP mRNA, lead acetate results in increased expression of GFAP protein CTD PMID:17047031 more ... lead diacetate increases expression ISO RGD:10633 6480464 lead acetate results in increased expression of GFAP mRNA, lead acetate results in increased expression of GFAP protein CTD PMID:21322097 , PMID:36539177 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of GFAP protein CTD PMID:20829427 lead nitrate multiple interactions EXP 6480464 Ashwagandha inhibits the reaction [lead nitrate results in increased expression of GFAP mRNA], Ashwagandha inhibits the reaction [lead nitrate results in increased expression of GFAP protein] CTD PMID:24987671 lead nitrate increases expression EXP 6480464 lead nitrate results in increased expression of GFAP mRNA, lead nitrate results in increased expression of GFAP protein CTD PMID:24987671 lead(0) affects expression ISO RGD:619574 6480464 Lead affects the expression of GFAP mRNA CTD PMID:28903495 lead(0) increases expression ISO RGD:10633 6480464 Lead results in increased expression of GFAP mRNA, Lead results in increased expression of GFAP protein CTD PMID:34742682 lead(0) multiple interactions ISO RGD:10633 6480464 Dietary Fats promotes the reaction [Lead results in increased expression of GFAP mRNA] more ... CTD PMID:34742682 lead(2+) affects expression ISO RGD:619574 6480464 Lead affects the expression of GFAP mRNA CTD PMID:28903495 lead(2+) multiple interactions ISO RGD:10633 6480464 Dietary Fats promotes the reaction [Lead results in increased expression of GFAP mRNA] more ... CTD PMID:34742682 lead(2+) increases expression ISO RGD:10633 6480464 Lead results in increased expression of GFAP mRNA, Lead results in increased expression of GFAP protein CTD PMID:34742682 lead(II) chloride decreases expression EXP 6480464 lead chloride results in decreased expression of GFAP mRNA CTD PMID:19651682 lipoic acid decreases expression ISO RGD:10633 6480464 Thioctic Acid results in decreased expression of GFAP mRNA CTD PMID:19555370 lipopolysaccharide increases expression ISO RGD:10633 6480464 Lipopolysaccharides results in increased expression of GFAP protein CTD PMID:26954031 , PMID:34474083 lipopolysaccharide multiple interactions ISO RGD:10633 6480464 AGT protein modified form promotes the reaction [FXN gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of GFAP protein]] more ... CTD PMID:26954031 , PMID:34474083 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of GFAP protein CTD PMID:12967722 more ... lipopolysaccharide multiple interactions EXP 6480464 [Chlorpyrifos co-treated with Lipopolysaccharides] results in increased expression of GFAP protein more ... CTD PMID:24481447 more ... lithium chloride multiple interactions ISO RGD:619574 6480464 Lithium Chloride inhibits the reaction [wogonin results in increased expression of GFAP protein] CTD PMID:23872260 lithium chloride multiple interactions EXP 6480464 [Lithium Chloride co-treated with Pilocarpine] results in increased expression of GFAP mRNA more ... CTD PMID:23872260 , PMID:31018114 luteolin multiple interactions ISO RGD:10633 6480464 Luteolin inhibits the reaction [Carbon Tetrachloride results in increased expression of GFAP protein] CTD PMID:19747501 lycopene decreases expression ISO RGD:10633 6480464 lycopene results in decreased expression of GFAP mRNA CTD PMID:19555370 lycopene multiple interactions EXP 6480464 Lycopene inhibits the reaction [Oxaliplatin results in increased expression of GFAP protein] CTD PMID:32544411 Magnolol multiple interactions ISO RGD:10633 6480464 magnolol inhibits the reaction [trimethyltin results in increased expression of GFAP protein] CTD PMID:26756313 maneb multiple interactions ISO RGD:10633 6480464 [Paraquat co-treated with Maneb] results in increased expression of GFAP protein, acetovanillone inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of GFAP protein] CTD PMID:30797899 manganese atom affects expression EXP 6480464 Manganese affects the expression of GFAP protein CTD PMID:24885898 manganese atom increases expression ISO RGD:10633 6480464 Manganese results in increased expression of GFAP mRNA, Manganese results in increased expression of GFAP protein CTD PMID:23832297 manganese atom increases expression EXP 6480464 Manganese results in increased expression of GFAP mRNA, Manganese results in increased expression of GFAP protein CTD PMID:19782702 , PMID:20224926 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of GFAP mRNA CTD PMID:20224926 manganese(0) affects expression EXP 6480464 Manganese affects the expression of GFAP protein CTD PMID:24885898 manganese(0) increases expression ISO RGD:10633 6480464 Manganese results in increased expression of GFAP mRNA, Manganese results in increased expression of GFAP protein CTD PMID:23832297 manganese(0) increases expression EXP 6480464 Manganese results in increased expression of GFAP mRNA, Manganese results in increased expression of GFAP protein CTD PMID:19782702 , PMID:20224926 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of GFAP mRNA CTD PMID:20224926 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of GFAP protein CTD PMID:12009774 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of GFAP protein CTD PMID:12106697 , PMID:24060432 manganese(II) chloride multiple interactions ISO RGD:10633 6480464 Melatonin inhibits the reaction [manganese chloride results in increased expression of GFAP protein] CTD PMID:25288107 manganese(II) chloride increases expression ISO RGD:10633 6480464 manganese chloride results in increased expression of GFAP protein CTD PMID:25288107 , PMID:28539244 manganese(II) chloride decreases expression ISO RGD:10633 6480464 manganese chloride results in decreased expression of GFAP protein CTD PMID:24969583 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Carmustine results in decreased expression of GFAP protein], Melatonin inhibits the reaction [Galactose results in increased expression of GFAP protein] CTD PMID:17572393 , PMID:34673010 melatonin multiple interactions ISO RGD:10633 6480464 Melatonin inhibits the reaction [manganese chloride results in increased expression of GFAP protein] CTD PMID:25288107 memantine multiple interactions EXP 6480464 Memantine inhibits the reaction [Streptozocin results in increased expression of GFAP mRNA], Memantine inhibits the reaction [Streptozocin results in increased expression of GFAP protein] CTD PMID:24333387 memantine multiple interactions ISO RGD:10633 6480464 Memantine inhibits the reaction [Lipopolysaccharides results in increased expression of GFAP protein] CTD PMID:34474083 mepanipyrim multiple interactions ISO RGD:10633 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of GFAP protein CTD PMID:31939705 mepanipyrim multiple interactions ISO RGD:619574 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of GFAP protein] CTD PMID:31939705 metformin multiple interactions ISO RGD:10633 6480464 Metformin inhibits the reaction [Olanzapine results in increased expression of GFAP mRNA] CTD PMID:32652086 methamphetamine multiple interactions ISO RGD:10633 6480464 3-((3 more ... CTD PMID:16088948 more ... methamphetamine increases expression ISO RGD:10633 6480464 Methamphetamine results in increased expression of GFAP mRNA, Methamphetamine results in increased expression of GFAP protein CTD PMID:12766323 more ... methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of GFAP mRNA, Methamphetamine results in increased expression of GFAP protein CTD PMID:10773198 more ... methamphetamine affects expression EXP 6480464 Methamphetamine affects the expression of GFAP protein CTD PMID:17262233 methapyrilene decreases methylation ISO RGD:619574 6480464 Methapyrilene results in decreased methylation of GFAP exon CTD PMID:30157460 methimazole increases expression EXP 6480464 Methimazole results in increased expression of GFAP protein CTD PMID:22504374 methionine sulfoximine increases expression EXP 6480464 Methionine Sulfoximine results in increased expression of GFAP protein CTD PMID:2565645 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of GFAP mRNA, Methotrexate results in decreased expression of GFAP protein CTD PMID:30502384 methotrexate decreases expression ISO RGD:10633 6480464 Methotrexate results in decreased expression of GFAP protein CTD PMID:30502384 methotrexate multiple interactions ISO RGD:10633 6480464 Folic Acid inhibits the reaction [Methotrexate results in decreased expression of GFAP mRNA], Folic Acid inhibits the reaction [Methotrexate results in decreased expression of GFAP protein] CTD PMID:30502384 methotrexate multiple interactions EXP 6480464 DHFR protein inhibits the reaction [Methotrexate results in decreased expression of GFAP mRNA], Folic Acid inhibits the reaction [Methotrexate results in decreased expression of GFAP mRNA] CTD PMID:30502384 methylene blue multiple interactions ISO RGD:10633 6480464 Methylene Blue inhibits the reaction [MAPT protein mutant form results in increased expression of GFAP mRNA], Methylene Blue inhibits the reaction [MAPT protein mutant form results in increased expression of GFAP protein] CTD PMID:24556215 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of GFAP mRNA, methylmercuric chloride results in increased expression of GFAP protein CTD PMID:28821999 more ... methylmercury chloride affects expression ISO RGD:10633 6480464 methylmercuric chloride affects the expression of GFAP protein CTD PMID:33301842 methylmercury chloride multiple interactions ISO RGD:10633 6480464 [GHRL protein co-treated with methylmercuric chloride] affects the expression of GFAP protein CTD PMID:33301842 methylmercury chloride multiple interactions EXP 6480464 fisetin inhibits the reaction [methylmercuric chloride results in increased expression of GFAP protein] CTD PMID:30890323 methylmercury chloride increases expression ISO RGD:619574 6480464 methylmercuric chloride results in increased expression of GFAP mRNA CTD PMID:27729293 microcystin LF increases degradation EXP 6480464 microcystin-LF results in increased degradation of GFAP protein CTD PMID:27864109 microcystin-LR decreases expression EXP 6480464 cyanoginosin LR results in decreased expression of GFAP protein CTD PMID:22430071 monocrotaline affects expression EXP 6480464 Monocrotaline affects the expression of GFAP protein CTD PMID:21781985 monosodium L-glutamate increases expression EXP 6480464 Sodium Glutamate results in increased expression of GFAP mRNA CTD PMID:20928830 morin multiple interactions EXP 6480464 morin inhibits the reaction [Ifosfamide results in increased expression of GFAP protein] CTD PMID:31722249 morphine decreases expression ISO RGD:10633 6480464 Morphine results in decreased expression of GFAP mRNA CTD PMID:21955143 morphine multiple interactions EXP 6480464 [lead acetate co-treated with Morphine] results in increased expression of GFAP mRNA CTD PMID:26478469 N,N-diethyl-m-toluamide increases expression EXP 6480464 DEET results in increased expression of GFAP protein CTD PMID:11681848 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [DEET co-treated with Permethrin] results in increased expression of GFAP protein CTD PMID:11681848 N-acetyl-L-cysteine multiple interactions ISO RGD:10633 6480464 Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of GFAP protein] CTD PMID:28499986 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of GFAP protein] CTD PMID:31173782 N-methyl-4-phenylpyridinium increases expression ISO RGD:10633 6480464 1-Methyl-4-phenylpyridinium results in increased expression of GFAP mRNA CTD PMID:15140182 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of GFAP protein CTD PMID:18155124 N-methyl-N-nitrosourea decreases expression EXP 6480464 Methylnitrosourea results in decreased expression of GFAP mRNA CTD PMID:28688903 N-nitrosodiethylamine affects expression EXP 6480464 Diethylnitrosamine affects the expression of GFAP mRNA CTD PMID:20387270 NADP zwitterion multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of GFAP protein] CTD PMID:32057834 NADP(+) multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of GFAP protein] CTD PMID:32057834 nicotine increases expression ISO RGD:10633 6480464 Nicotine results in increased expression of GFAP mRNA CTD PMID:17997037 nicotine decreases expression ISO RGD:10633 6480464 Nicotine results in decreased expression of GFAP mRNA CTD PMID:21955143 nifedipine multiple interactions EXP 6480464 Nifedipine inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] CTD PMID:21863293 nitric oxide decreases expression EXP 6480464 Nitric Oxide deficiency results in decreased expression of GFAP protein CTD PMID:15763998 O-acetyl-L-carnitine decreases expression ISO RGD:10633 6480464 Acetylcarnitine results in decreased expression of GFAP mRNA CTD PMID:19555370 ochratoxin A multiple interactions EXP 6480464 15-deoxy-delta(12 more ... CTD PMID:15994020 , PMID:24792326 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of GFAP mRNA, ochratoxin A results in decreased expression of GFAP protein CTD PMID:15994020 more ... olanzapine multiple interactions ISO RGD:10633 6480464 capsazepine inhibits the reaction [Olanzapine results in increased expression of GFAP mRNA] more ... CTD PMID:32652086 olanzapine increases expression ISO RGD:10633 6480464 Olanzapine results in increased expression of GFAP mRNA CTD PMID:32652086 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of GFAP mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 Oxaliplatin results in increased expression of GFAP protein CTD PMID:32544411 oxaliplatin multiple interactions EXP 6480464 Lycopene inhibits the reaction [Oxaliplatin results in increased expression of GFAP protein] CTD PMID:32544411 oxidopamine multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Oxidopamine results in increased expression of GFAP protein], Rosiglitazone promotes the reaction [Oxidopamine results in increased expression of GFAP protein] CTD PMID:22842585 , PMID:34302886 oxidopamine decreases expression EXP 6480464 Oxidopamine results in decreased expression of GFAP protein CTD PMID:24486959 oxidopamine increases expression EXP 6480464 Oxidopamine results in increased expression of GFAP protein CTD PMID:22842585 , PMID:34302886 paclitaxel multiple interactions ISO RGD:619574 6480464 [Tretinoin co-treated with Paclitaxel] results in increased expression of GFAP protein CTD PMID:18098270 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of GFAP protein CTD PMID:16854522 , PMID:17005179 paclitaxel increases expression ISO RGD:619574 6480464 Paclitaxel results in increased expression of GFAP protein CTD PMID:18098270 paracetamol multiple interactions ISO RGD:10633 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GFAP mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GFAP mRNA] CTD PMID:17585979 paraquat increases expression ISO RGD:10633 6480464 Paraquat results in increased expression of GFAP protein CTD PMID:21688324 paraquat affects expression ISO RGD:619574 6480464 Paraquat affects the expression of GFAP mRNA CTD PMID:29454966 paraquat increases expression EXP 6480464 Paraquat results in increased expression of GFAP mRNA, Paraquat results in increased expression of GFAP protein CTD PMID:24521700 , PMID:28467894 paraquat increases expression ISO RGD:619574 6480464 Paraquat results in increased expression of GFAP mRNA, Paraquat results in increased expression of GFAP protein CTD PMID:25314302 more ... paraquat multiple interactions EXP 6480464 [Paraquat results in increased abundance of Reactive Oxygen Species] which results in increased expression of GFAP protein CTD PMID:24376630 paraquat multiple interactions ISO RGD:10633 6480464 [Paraquat co-treated with Maneb] results in increased expression of GFAP protein more ... CTD PMID:21688324 , PMID:30797899 perfluorohexanesulfonic acid decreases expression ISO RGD:619574 6480464 perfluorohexanesulfonic acid results in decreased expression of GFAP mRNA CTD PMID:25812627 perfluorononanoic acid decreases expression ISO RGD:619574 6480464 perfluoro-n-nonanoic acid results in decreased expression of GFAP mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of GFAP protein CTD PMID:20937303 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:619574 6480464 perfluorooctane sulfonic acid results in decreased expression of GFAP mRNA CTD PMID:25812627 perfluorooctanoic acid decreases expression ISO RGD:619574 6480464 perfluorooctanoic acid results in decreased expression of GFAP mRNA CTD PMID:25812627 permethrin increases expression ISO RGD:10633 6480464 Permethrin results in increased expression of GFAP protein CTD PMID:14555407 permethrin multiple interactions ISO RGD:10633 6480464 [Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of GFAP protein CTD PMID:27984134 permethrin increases expression EXP 6480464 Permethrin results in increased expression of GFAP protein CTD PMID:11681848 permethrin multiple interactions EXP 6480464 [DEET co-treated with Permethrin] results in increased expression of GFAP protein CTD PMID:11681848 phencyclidine increases expression ISO RGD:10633 6480464 Phencyclidine results in increased expression of GFAP mRNA CTD PMID:17266109 phenethyl caffeate multiple interactions EXP 6480464 NGFR protein affects the susceptibility to [caffeic acid phenethyl ester results in increased expression of GFAP protein] CTD PMID:20836997 phenethyl caffeate increases expression EXP 6480464 caffeic acid phenethyl ester results in increased expression of GFAP protein CTD PMID:20836997 Phenoxybenzamine increases expression EXP 6480464 Phenoxybenzamine results in increased expression of GFAP protein CTD PMID:17845906 physostigmine multiple interactions ISO RGD:10633 6480464 Physostigmine inhibits the reaction [Streptozocin results in decreased expression of GFAP protein] CTD PMID:28499986 poly(I:C) increases expression EXP 6480464 Poly I-C results in increased expression of GFAP mRNA CTD PMID:27317300 potassium chloride increases expression EXP 6480464 Potassium Chloride results in increased expression of GFAP protein CTD PMID:27422357 probenecid multiple interactions ISO RGD:10633 6480464 [1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 , PMID:28807673 probucol multiple interactions EXP 6480464 NFE2L2 protein affects the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of GFAP protein]], Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of GFAP protein] CTD PMID:28881715 progesterone multiple interactions ISO RGD:10633 6480464 [Estradiol co-treated with Progesterone] promotes the reaction [Cuprizone results in increased expression of GFAP mRNA] CTD PMID:19031445 progesterone increases expression EXP 6480464 Progesterone results in increased expression of GFAP mRNA CTD PMID:19360904 , PMID:21770760 progesterone decreases expression ISO RGD:10633 6480464 Progesterone results in decreased expression of GFAP protein CTD PMID:23157231 progesterone multiple interactions EXP 6480464 Finasteride inhibits the reaction [Progesterone results in increased expression of GFAP mRNA] CTD PMID:19360904 propiconazole multiple interactions EXP 6480464 carvacrol inhibits the reaction [propiconazole results in increased expression of GFAP protein] CTD PMID:29852196 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of GFAP protein CTD PMID:29852196 propionic acid increases expression EXP 6480464 propionic acid results in increased expression of GFAP protein CTD PMID:16950524 Pyridostigmine bromide multiple interactions ISO RGD:10633 6480464 [Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of GFAP protein CTD PMID:27984134 pyrimethanil multiple interactions ISO RGD:10633 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of GFAP protein CTD PMID:31939705 pyrimethanil multiple interactions ISO RGD:619574 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of GFAP protein] CTD PMID:31939705 pyrithiamine increases expression EXP 6480464 Pyrithiamine results in increased expression of GFAP protein CTD PMID:27984051 pyrrolidine dithiocarbamate multiple interactions ISO RGD:10633 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased expression of GFAP mRNA] CTD PMID:36539177 pyrroloquinoline quinone increases expression ISO RGD:619574 6480464 PQQ Cofactor results in increased expression of GFAP mRNA CTD PMID:28578007 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Vincristine results in increased expression of GFAP protein] CTD PMID:33038355 reactive oxygen species multiple interactions EXP 6480464 [Paraquat results in increased abundance of Reactive Oxygen Species] which results in increased expression of GFAP protein CTD PMID:24376630 resveratrol multiple interactions ISO RGD:10633 6480464 Resveratrol inhibits the reaction [Aluminum Chloride results in increased expression of GFAP protein] more ... CTD PMID:17581637 more ... resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of GFAP protein CTD PMID:27093858 resveratrol multiple interactions ISO RGD:619574 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of GFAP mRNA more ... CTD PMID:22530672 , PMID:23557933 resveratrol increases expression ISO RGD:619574 6480464 resveratrol results in increased expression of GFAP protein CTD PMID:22530672 , PMID:23651583 resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of GFAP protein] more ... CTD PMID:17888892 more ... rimonabant decreases expression ISO RGD:10633 6480464 Rimonabant results in decreased expression of GFAP protein CTD PMID:21373835 rimonabant multiple interactions ISO RGD:10633 6480464 Rimonabant inhibits the reaction [Dronabinol results in increased expression of GFAP mRNA] CTD PMID:36529297 rotenone increases expression EXP 6480464 Rotenone results in increased expression of GFAP protein CTD PMID:23098804 , PMID:27316720 rotenone multiple interactions EXP 6480464 caryophyllene inhibits the reaction [Rotenone results in increased expression of GFAP protein] CTD PMID:27316720 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of GFAP mRNA CTD PMID:28374803 ruthenium red multiple interactions ISO RGD:10633 6480464 Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of GFAP mRNA] CTD PMID:32652086 sarin multiple interactions ISO RGD:10633 6480464 8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [[Sarin co-treated with 2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide] results in increased expression of GFAP protein], [Sarin co-treated with 2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide] results in increased expression of GFAP protein CTD PMID:23692952 sarin increases expression EXP 6480464 Sarin results in increased expression of GFAP protein CTD PMID:27639427 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA], SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein] CTD PMID:34571074 SB 431542 increases expression ISO RGD:619574 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of GFAP protein CTD PMID:25670856 SCH 23390 multiple interactions ISO RGD:10633 6480464 SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of GFAP protein] CTD PMID:16088948 scopolamine multiple interactions ISO RGD:10633 6480464 Ashwagandha inhibits the reaction [Scopolamine results in decreased expression of GFAP mRNA] more ... CTD PMID:22096544 scopolamine decreases expression ISO RGD:10633 6480464 Scopolamine results in decreased expression of GFAP mRNA, Scopolamine results in decreased expression of GFAP protein CTD PMID:22096544 sodium arsenite decreases expression ISO RGD:619574 6480464 sodium arsenite results in decreased expression of GFAP mRNA CTD PMID:19615344 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of GFAP mRNA, sodium arsenite results in decreased expression of GFAP protein CTD PMID:20829427 , PMID:29228391 sodium arsenite multiple interactions EXP 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:20829427 more ... sodium chloride decreases expression EXP 6480464 Sodium Chloride results in decreased expression of GFAP protein CTD PMID:16280599 sodium chloride increases expression EXP 6480464 Sodium Chloride results in increased expression of GFAP mRNA CTD PMID:22954530 Soman increases expression EXP 6480464 Soman results in increased expression of GFAP mRNA CTD PMID:19281266 staurosporine multiple interactions EXP 6480464 Staurosporine inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] CTD PMID:21879721 sterigmatocystin decreases expression EXP 6480464 Sterigmatocystin results in decreased expression of GFAP mRNA CTD PMID:34126181 streptozocin multiple interactions EXP 6480464 Ibuprofen inhibits the reaction [Streptozocin results in increased expression of GFAP mRNA] more ... CTD PMID:24333387 streptozocin multiple interactions ISO RGD:10633 6480464 Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of GFAP protein], Physostigmine inhibits the reaction [Streptozocin results in decreased expression of GFAP protein] CTD PMID:28499986 streptozocin decreases expression ISO RGD:10633 6480464 Streptozocin results in decreased expression of GFAP protein CTD PMID:28499986 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of GFAP mRNA, Streptozocin results in increased expression of GFAP protein CTD PMID:24333387 strychnine increases expression EXP 6480464 Strychnine results in increased expression of GFAP mRNA CTD PMID:22954530 tadalafil multiple interactions ISO RGD:10633 6480464 Tadalafil inhibits the reaction [Thioacetamide results in increased expression of GFAP protein] CTD PMID:31323263 tamibarotene increases expression EXP 6480464 tamibarotene results in increased expression of GFAP CTD PMID:19182380 tamoxifen affects expression ISO RGD:10633 6480464 Tamoxifen affects the expression of GFAP mRNA CTD PMID:17555576 tamoxifen multiple interactions ISO RGD:10633 6480464 Tamoxifen inhibits the reaction [bisphenol A results in increased expression of GFAP protein] CTD PMID:16860915 Tanshinone I increases expression ISO RGD:619574 6480464 tanshinone results in increased expression of GFAP mRNA, tanshinone results in increased expression of GFAP protein CTD PMID:16955220 telmisartan multiple interactions ISO RGD:10633 6480464 telmisartan inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23747572 telmisartan decreases expression EXP 6480464 Telmisartan results in decreased expression of GFAP protein CTD PMID:29909460 temozolomide multiple interactions ISO RGD:619574 6480464 resveratrol promotes the reaction [temozolomide results in increased expression of GFAP protein], temozolomide promotes the reaction [resveratrol results in increased expression of GFAP protein] CTD PMID:22530672 temozolomide increases expression ISO RGD:619574 6480464 temozolomide results in increased expression of GFAP protein CTD PMID:22530672 terbutaline increases expression EXP 6480464 Terbutaline results in increased expression of GFAP protein CTD PMID:14610225 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of GFAP protein CTD PMID:24394546 tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of GFAP protein CTD PMID:24394546 testosterone decreases expression ISO RGD:10633 6480464 Testosterone results in decreased expression of GFAP mRNA CTD PMID:19693291 testosterone increases expression ISO RGD:619574 6480464 Testosterone results in increased expression of GFAP mRNA CTD PMID:33359661 tetrachloroethene decreases expression EXP 6480464 Tetrachloroethylene results in decreased expression of GFAP protein CTD PMID:8372046 tetrachloromethane increases expression ISO RGD:10633 6480464 Carbon Tetrachloride results in increased expression of GFAP protein CTD PMID:19747501 tetrachloromethane multiple interactions ISO RGD:10633 6480464 Luteolin inhibits the reaction [Carbon Tetrachloride results in increased expression of GFAP protein] CTD PMID:19747501 thiacloprid multiple interactions ISO RGD:10633 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of GFAP protein CTD PMID:32736067 thioacetamide increases expression ISO RGD:10633 6480464 Thioacetamide results in increased expression of GFAP protein CTD PMID:31323263 thioacetamide multiple interactions EXP 6480464 alloin inhibits the reaction [Thioacetamide results in increased expression of GFAP protein] CTD PMID:30380640 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GFAP mRNA, Thioacetamide results in increased expression of GFAP protein CTD PMID:30380640 , PMID:34492290 thioacetamide multiple interactions ISO RGD:10633 6480464 Tadalafil inhibits the reaction [Thioacetamide results in increased expression of GFAP protein] CTD PMID:31323263 thiophanate-methyl multiple interactions ISO RGD:10633 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of GFAP protein CTD PMID:32736067 toluene increases expression EXP 6480464 Toluene results in increased expression of GFAP mRNA, Toluene results in increased expression of GFAP protein CTD PMID:10987130 , PMID:22166486 toluene increases expression ISO RGD:10633 6480464 Toluene results in increased expression of GFAP mRNA CTD PMID:21381054 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of GFAP protein CTD PMID:23743147 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of GFAP protein CTD PMID:23743147 , PMID:26079211 tributylstannane multiple interactions EXP 6480464 Phycocyanin inhibits the reaction [tributyltin results in increased expression of GFAP protein] CTD PMID:26079211 trichostatin A multiple interactions EXP 6480464 Finasteride inhibits the reaction [trichostatin A results in increased expression of GFAP mRNA], Finasteride inhibits the reaction [trichostatin A results in increased expression of GFAP protein] CTD PMID:19360904 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of GFAP mRNA, trichostatin A results in increased expression of GFAP protein CTD PMID:19360904 triclosan decreases expression ISO RGD:619574 6480464 Triclosan results in decreased expression of GFAP mRNA CTD PMID:30510588 trimethyltin increases expression ISO RGD:10633 6480464 trimethyltin results in increased expression of GFAP mRNA, trimethyltin results in increased expression of GFAP protein CTD PMID:24002884 , PMID:26756313 trimethyltin increases expression ISO RGD:619574 6480464 trimethyltin results in increased expression of GFAP mRNA CTD PMID:27729293 trimethyltin multiple interactions ISO RGD:10633 6480464 magnolol inhibits the reaction [trimethyltin results in increased expression of GFAP protein] CTD PMID:26756313 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of GFAP mRNA CTD PMID:33078273 triptonide increases expression ISO RGD:10633 6480464 triptonide results in increased expression of GFAP mRNA CTD PMID:33045310 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of GFAP mRNA, troglitazone results in decreased expression of GFAP protein CTD PMID:24481447 troglitazone multiple interactions EXP 6480464 [Troglitazone results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:24481447 U-73122 multiple interactions EXP 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:21879721 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of GFAP mRNA, Valproic Acid results in decreased expression of GFAP protein CTD PMID:18585900 , PMID:22954530 valproic acid decreases expression ISO RGD:10633 6480464 Valproic Acid results in decreased expression of GFAP mRNA CTD PMID:30578912 valproic acid increases methylation ISO RGD:619574 6480464 Valproic Acid results in increased methylation of GFAP gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of GFAP mRNA, Valproic Acid results in increased expression of GFAP protein CTD PMID:19360904 valproic acid multiple interactions EXP 6480464 Finasteride inhibits the reaction [Valproic Acid results in increased expression of GFAP mRNA], Finasteride inhibits the reaction [Valproic Acid results in increased expression of GFAP protein] CTD PMID:19360904 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of GFAP mRNA CTD PMID:25423262 verapamil multiple interactions EXP 6480464 Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein], Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] CTD PMID:21863293 , PMID:21879721 verapamil increases expression EXP 6480464 Verapamil results in increased expression of GFAP mRNA CTD PMID:22954530 vincristine multiple interactions ISO RGD:10633 6480464 Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of GFAP protein], KN 93 inhibits the reaction [Vincristine results in increased expression of GFAP protein] CTD PMID:34286406 vincristine increases expression EXP 6480464 Vincristine results in increased expression of GFAP protein CTD PMID:33038355 vincristine multiple interactions EXP 6480464 Quercetin inhibits the reaction [Vincristine results in increased expression of GFAP protein] CTD PMID:33038355 vincristine increases expression ISO RGD:10633 6480464 Vincristine results in increased expression of GFAP protein CTD PMID:34286406 vitamin E multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Aluminum results in increased expression of GFAP protein] CTD PMID:16545059 warfarin increases expression ISO RGD:10633 6480464 Warfarin results in increased expression of GFAP mRNA, Warfarin results in increased expression of GFAP protein CTD PMID:27397090 wogonin multiple interactions ISO RGD:619574 6480464 Lithium Chloride inhibits the reaction [wogonin results in increased expression of GFAP protein] CTD PMID:23872260 wogonin increases expression ISO RGD:619574 6480464 wogonin results in increased expression of GFAP protein CTD PMID:23872260 wogonin increases expression EXP 6480464 wogonin results in increased expression of GFAP protein CTD PMID:23872260 wogonin multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [wogonin results in increased expression of GFAP protein] CTD PMID:23872260 ziram multiple interactions ISO RGD:10633 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of GFAP protein CTD PMID:32736067 zonisamide multiple interactions ISO RGD:10633 6480464 zonisamide inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:19199078
